Why is MLYS Down Today?
About Mineralys Therapeutics, Inc. Common Stock
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that ...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
NORMAL - This move is backed by significant volume and appears sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.5%
Market Comparison
🔔 Get MLYS Alerts
We'll notify you when MLYS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
MLYS has moved more than 3.0% down on 37 occasions in the past year.
Frequently Asked Questions
Why is MLYS stock down today?
MLYS is down 3.3% today on 1.3x average volume. The move appears to be driven by general market sentiment and momentum traders.
Is MLYS stock a buy or sell right now?
Based on current analysis, MLYS shows 60% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →
What is the MLYS stock price target?
MLYS is currently trading at $28.34. Based on today's momentum, the expected short-term range is $27.49 - $28.91. See long-term price prediction →
Will MLYS stock continue falling?
Our analysis shows a 45% probability that MLYS's move continues in the next 1-3 days. Key level to watch: $26.92 (support).
Is MLYS stock oversold or overbought?
MLYS's RSI (Relative Strength Index) is currently at 53.6. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for MLYS stock?
MLYS's 10-day momentum indicator is at 2.19. Strong bullish momentum - the stock is gaining significant upward force. This often precedes continued gains.
Is MLYS outperforming or underperforming the market?
MLYS (-3.28%) is currently significantly underperforming the market (-4.1% vs SPY). Today, the S&P 500 (SPY) is up 0.85%, and Nasdaq (QQQ) is up 0.87%.
What does MACD indicate for MLYS?
MLYS's MACD (0.77) is currently above the signal line (0.45), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 20.2) is moderate.
Is MLYS in an uptrend or downtrend?
Based on moving average analysis, MLYS is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $27.08, 50-day SMA: $27.23.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis